Back
Viking Therapeutics Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Buy
51
VKTX
Viking Therapeutics
Last Price:
$27.57
Seasonality Move:
10.89%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
The current trend is relatively stagnant and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.
Viking Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.29 | Sell |
| 20-day SMA: | 26.16 | Buy |
| 50-day SMA: | 26.51 | Buy |
| 200-day SMA: | 45.9 | Sell |
| 8-day EMA: | 27.67 | Sell |
| 20-day EMA: | 26.8 | Buy |
| 50-day EMA: | 27.79 | Sell |
| 200-day EMA: | 39.22 | Sell |
Viking Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.64 | Buy |
| Relative Strength Index (14 RSI): | 53.68 | Buy |
| Chaikin Money Flow: | -1466406 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.6 - 27.94) | Buy |
| Bollinger Bands (100): | (24.8 - 38.26) | Sell |
Viking Therapeutics Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viking Therapeutics Stock
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 27.55 while VKTX 8-day simple moving average is 28.29, which is a Sell signal.
-
The stock price of VKTX is 27.55 while Viking Therapeutics 20-day SMA is 26.16, which makes it a Buy.
-
Viking Therapeutics 50-day simple moving average is 26.51 while VKTX share price is 27.55, making it a Buy technically.
-
VKTX stock price is 27.55 and Viking Therapeutics 200-day simple moving average is 45.90, creating a Sell signal.
VKTX Technical Analysis vs Fundamental Analysis
Buy
51
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy or a Sell?
-
Viking Therapeutics stock is rated a BuyThe current Viking Therapeutics [VKTX] share price is $27.55. The Score for VKTX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
Viking Therapeutics Stock Info
Market Cap:
3.1B
Price in USD:
27.55
Share Volume:
1.7M
Viking Therapeutics 52-Week Range
52-Week High:
81.73
52-Week Low:
18.92
Buy
51
Viking Therapeutics (VKTX)
is a Buy
Viking Therapeutics Share Price Forecast
-
What is the Viking Therapeutics stock price today?The Viking Therapeutics stock price is 27.55 USD today.
-
Will VKTX stock go up or go down?Viking Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Viking Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics is not overvalued.
Is Viking Therapeutics Stock a Buy?
-
Viking Therapeutics share price is 27.55 while VKTX 8-day exponential moving average is 27.67, which is a Sell signal.
-
The stock price of VKTX is 27.55 while Viking Therapeutics 20-day EMA is 26.80, which makes it a Buy.
-
Viking Therapeutics 50-day exponential moving average is 27.79 while VKTX share price is 27.55, making it a Sell technically.
-
VKTX stock price is 27.55 and Viking Therapeutics 200-day simple moving average is 39.22, creating a Sell signal.
Fundamental Analysis of Viking Therapeutics
Is Viking Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.28 per share, a decrease this year of $0.88 per share, and a decrease next year of $0.64 per share.
Technical Analysis of Viking Therapeutics
Should I short Viking Therapeutics stock?
-
VKTX Moving Average Covergence Divergence (MACD) indicator is 0.64, suggesting Viking Therapeutics is a Buy
-
Viking Therapeutics Relative Strength Index (RSI) is 53.68, which suggest Viking Therapeutics is overbought
-
The Bollinger Bands (25) for Viking Therapeutics is (22.6 - 27.94), which suggest Viking Therapeutics is a Sell
-
The Bollinger Bands (100) for Viking Therapeutics is (24.8 - 38.26), which suggest Viking Therapeutics is a Sell
* Viking Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.